You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Home Monitoring of Metabolic Disorders

    SBC: SEQUITUR HEALTH CORP            Topic: NICHD

    PROJECT SUMMARY This proposal is submitted in direct response to NOT-HD-22-009 Notice of Special Interest (NOSI): Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities [IDD] (R43/R44). Persons of all ages with certain metabolic disorders are at-risk for metabolic crises when a certain metabolite accumulates, whi ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Islet dosing and loading density in injection molded macroencapsulation devices

    SBC: IMMUNOSHIELD THERAPEUTICS INC.            Topic: 200

    PROJECT SUMMARY/ABSTRACT: Clinical islet transplantation is a promising alternative therapy for the treatment of type 1 diabetes, with the potential to reduce or eliminate secondary complications and adverse events. The potent immune response to islets remains the greatest challenge to long-term engraftment and function, which necessitates large numbers of islets and typically multiple pancreatic ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Accelerated absorption of insulin via a subcutaneously implanted, vascularized micro-chamber

    SBC: PROCYON TECHNOLOGIES LLC            Topic: 200

    Project Summary In Type I diabetic (T1D) patients, insulin is injected into the subcutaneous (SC) tissue, by needle or a pump and SC cannula. A bolus of insulin SC reaches its peak in about one hour or more. This slow absorption is in dramatic contrast to the secretion of insulin into the blood by the normal human pancreas, a process measured in seconds. Consequently, patients with T1D often strug ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Automated Seizure Detection for Home Seizure Monitoring with Epilog Sensors

    SBC: EPITEL, INC.            Topic: 105

    ABSTRACT Aura is a digital health platform that uses Epilog™, a miniature, wireless, wearable EEG sensor worn on the scalp below hairline that can record clinical and subclinical seizures. After an initial diagnosis of epilepsy, an epileptologist will use known information about patients’ seizures to guide the best scalp location to place the Epilog EEG sensor (A). EEG data is continuously tra ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  5. High density chronic optogenetic interface for primate brains

    SBC: BLACKROCK MICROSYSTEMS, INC            Topic: 101

    PROJECT SUMMARY Understanding the function of neural circuits in the cerebral cortex of the non-human primate (NHP), the model system closest to human, is crucial to understanding normal cortical function and the circuit-level basis of human brain disorders. Optogenetics has become a powerful tool for studying neural circuit function, but challenges remain in its application to NHPs. Large volume ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  6. Novel Broad-Spectrum Point-of-Care Coagulometer

    SBC: PEROSPHERE TECHNOLOGIES INC.            Topic: NHLBI

    Project Summary/Abstract Work under this proposal supports development of a broad-spectrum point-of-care (POC) coagulometer by Perosphere Technologies (The Perosphere Technologies POC Coagulometer) with the intent to create and offer an automated, microfluidic version of the manual Lee/White clotting time method. The device is based on novel technology and utilizes reagent-less, single-use microfl ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Biomechanical Evaluation of a Novel, Compliant Low Profile Prosthetic Foot

    SBC: LITTLE ROOM INNOVATIONS LLC            Topic: NICHD

    PROJECT SUMMARYWhile conventional wisdom holds that individuals with longer residual limbs retain greater function, they are actually confined to low-profile feet that limit performance. In particular, low-profile feet are often much stiffer than their standard profile counterparts. As such, many of the individuals with transtibial amputation that have long residual limbs are unable to obtain pros ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Amino Acids and Pediatric Hepatic Steatosis

    SBC: THE AMINO COMPANY LLC            Topic: 300

    7. Project Summary/Abstract Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in North America (1). Hepatic steatosis (HS) is the hallmark of NAFLD (2). NAFLD may transition in sub-groups to chronic inflammation (non- alcoholic steatohepatitis, NASH), and ultimately to cirrhosis. HS is prevalent in all stages of NAFLD. 3-10% of all children in the US and 40-70% of obese ch ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA

    SBC: BINARY GENOMICS, INC            Topic: 102

    ABSTRACT: Immunotherapies produce remarkable, long-term responses in subsets of patients with non-small cell lung cancer, but unfortunately, most patients do not respond to such treatment. Current biomarkers to predict which patients will benefit have limited accuracy, and decisions to continue or suspend treatment are mainly guided by monitoring of radiographic changes in tumor size. However, unu ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility

    SBC: INHERENT BIOSCIENCES, INC.            Topic: NICHD

    NIH SBIR Fast-Track Application: Inherent Biosciences SUMMARY/ABSTRACT Title: Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility39.7 million men worldwide (1% of the male population) suffer the severest form of male infertility: Non-Obstructive Azoospermia (NOA). These men have no identifiable sperm in their semen, greatly limiti ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government